[Cognitive Disorders and Dementia in Old Patients With Arterial Hypertension]

O D Ostroumova1, A V Starodubova2, T M Ostroumova3

  • 1Federal State Budgetary Educational Institution of Higher Education, "A. I. Evdokimov Moscow State University for Medicine and Dentistry" of the Ministry of Health of the Russian Federation.

Kardiologiia
|October 26, 2018
PubMed

Insights

This study reviews dementia, its types, and the link between high blood pressure and cognitive decline in older adults. It examines how certain blood pressure medications may help prevent dementia.

Area of Science:

  • Neurology
  • Geriatrics
  • Cardiology

Background:

  • Dementia encompasses various conditions affecting cognitive function.
  • Arterial hypertension is a significant risk factor for cognitive disorders and dementia, particularly in the elderly.
  • Understanding the interplay between hypertension and dementia is crucial for geriatric care.

Purpose of the Study:

  • To define dementia, its diagnostic criteria, and classifications.
  • To explore the relationship between arterial hypertension and the risk of cognitive decline and dementia.
  • To evaluate the impact of antihypertensive medications on dementia risk and cognitive function.

Main Methods:

  • Review of existing literature on dementia definition, diagnosis, and classification.
  • Analysis of studies investigating the association between arterial hypertension and dementia.
  • Examination of clinical trial data on antihypertensive drugs and their effects on cognition.

Main Results:

  • Dementia presents diverse pathogenetic and clinical profiles.
  • Arterial hypertension is strongly linked to increased dementia risk in older populations.
  • Specific antihypertensive drugs, including amlodipine and indapamide-retard, show potential in dementia prevention and cognitive improvement.

Conclusions:

  • Effective management of arterial hypertension is vital for mitigating dementia risk.
  • Amlodipine and indapamide-retard demonstrate a beneficial effect on cognitive function in hypertensive patients.
  • Further research into antihypertensive therapies for dementia prevention is warranted.

Related Concept Videos

Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
577
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
605
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
467
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
509
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
619
Cognitive Dissonance01:38

Cognitive Dissonance

Social psychologists have documented that feeling good about ourselves and maintaining positive self-esteem is a powerful motivator of human behavior (Tavris & Aronson, 2008). In the United States, members of the predominant culture typically think very highly of themselves and view themselves as good people who are above average on many desirable traits (Ehrlinger, Gilovich, & Ross, 2005). Often, our behavior, attitudes, and beliefs are affected when we experience a threat to our...
37.5K